A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer — Stella
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(10 sites)
Brazil
Hospital Brasilia, Brasília, Federal District
ICTR Curitiba, Curitiba, Paraná
Hospital Santa Rita de Cassia Vitoria, Curitiba, Pará
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, São Paulo, São Paulo
Canada
CIUSSS du Saguenay Lac-Saint-Jean, Chicoutimi Hospital, Chicoutimi, Quebec
McGill University, Montreal, Quebec
South Korea
Soon Chun Hyang University Cheonan Hospital, Dongnam-gu, Cheonan-si
Gachon University Gil Medical Center, Namdong-Gu
Seoul National University Bundang Hospital, Seongnam-si